Delivery Order SPE2DB20D9331-SPE2DB25FL1U3
- Not listed
- The Defense Logistics Agency issued a delivery order valued at $27,961.92 to DMS Pharmaceutical Group Inc. for the supply of 1,000 unit vials of Kcentra, a vitamin K-dependent clotting factor concentrate used for emergency reversal of anticoagulation. The award, effective August 25, 2025 with completion targeted for September 16, 2025, operates under a firm fixed-price delivery order structure with no set-aside designation. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical...
- The Defense Logistics Agency awarded a $7,296.00 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 1,000 unit vials of Kcentra. The delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, carries no set-aside designation. This award represents a delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,477.76 by the Defense Logistics Agency (DLA) on August 21, 2025. The contract calls for the delivery of 1,000 unit vials of Kcentra, a vitamin K-dependent clotting factor concentrate used in medical treatment. This delivery order was issued without a set-aside designation and carries an ultimate completion date of...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on July 25, 2025, by the Defense Logistics Agency (DLA) for 1,000 unit vials of Kcentra, a vitamin K-dependent clotting factor concentrate used to reverse anticoagulation. The firm fixed-price delivery order has a ceiling value of $19,845.12 with an ultimate completion date of August 15, 2025. This award was issued without a set-aside designation,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $9,977.28 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 500-unit vials of Kcentra, a blood coagulant medication, with a performance period ending on April 12, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract with DLA, valued at up to $4,999,999, which enables...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $93,282.40 by the Defense Logistics Agency (DLA) on August 28, 2025. The contract calls for the delivery of 1,000 unit vials of Kcentra, a vitamin K-dependent clotting factor concentrate used in medical settings. The delivery order carries an ultimate completion date of September 19, 2025, and was issued without a set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $9,539.52 by the Defense Logistics Agency on August 18, 2025, for the supply of Kcentra 500 unit vials. The contract carries an ultimate completion date of September 9, 2025, and is not designated under any set-aside program. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $10,944 to DMS Pharmaceutical Group Inc. for the supply of 500 unit vials of Kcentra, a prothrombin complex concentrate used for urgent reversal of warfarin anticoagulation in medical emergencies. The delivery order, issued on September 10, 2025, with an ultimate completion date of October 1, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical...
- This is a delivery order award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $71,947.68 firm fixed-price contract is for the delivery of 1,000 unit vials of the pharmaceutical product Kcentra, with a period of performance through May 2, 2024. The award is issued by the Defense Logistics Agency (DLA), a defense agency that provides supplies and services to the U.S. military. This delivery order is placed against DMS Pharmaceutical Group's...
- This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) for the supply of Kcentra 1,000 unit vials. The order, valued at $17,312.80, is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA for the provision of a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB25FL1U3Delivery Order
The Defense Logistics Agency awarded a $27,961.92 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on August 19, 2025, for 1,000 unit vials of Kcentra, a vitamin K-dependent clotting factor complex used for treating bleeding associated with warfarin or novel anticoagulant overdose. This delivery order, with an ultimate completion date of September 10, 2025, carries no set-aside designation and will be performed at the contractor's facility in Park Ridge, Illinois. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler that has maintained SAM.gov registration since 2001 and specializes in supplying medications and medical consumables to federal healthcare systems, particularly military facilities. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and extending through November 2026. The IDC enables DLA to procure a comprehensive range of pharmaceutical products, branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare sites worldwide. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has consistently secured contracts to deliver specialized medical products directly to military health facilities, leveraging its status as a woman-owned small business to compete effectively in federal procurement markets.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.0k | 8/19/25 |